University Children's Hospital Muenster Trials

University Children's Hospital Muenster	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Thurner, Lorenz

OPTIMAL>60, NCT01478542 / 2010-019587-36: / DR. CHOP, Improvement of Therapy of Elderly Patients with CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine

	ASH 2014
	Nov 2014 - Nov 2014: ASH 2014
	P3 enrollment initiation in 1st line, adult NHL pts
	Nov 2011 - Nov 2011: P3 enrollment initiation in 1st line, adult NHL pts

Completed

1152

Europe

Conventional Vincristine, Liposomal Vincristine, Ricover-scheme rituximab, optimised rituximab-schedule

Universität des Saarlandes, German High-Grade Non-Hodgkin's Lymphoma Study Group, Spectrum Pharmaceuticals, Inc

CD20+ Aggressive B-Cell Lymphoma

01/24

GRAPPA, NCT05153226: GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG

Active, not recruiting

640

Europe

Cyclophosphamide, all brands, ATG, ATG Grafalon

DKMS gemeinnützige GmbH

Graft Vs Host Disease, Peripheral Blood Stem Cell Transplantation, AML, MDS, MDS/MPN, CMML

06/25

12/26

PERIPLO, NCT05925790: Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR Levels

Recruiting

N/A

146

Europe

IL1RA Antibody Assay, suPAR Testing

ASST Fatebenefratelli Sacco, Fatebenefratelli Hospital, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Ospedale Galeazzi Sant'Ambrogio - IRCCS, Careggi Hospital, Azienda Ospedaliero Universitaria, Santa Maria della Misericordia di Udine, Italy, Children's Medical Hospital, University of Muenster, Muenster, Germany, University of Homburg, University Hospital Tuebingen

Pericarditis

07/25

12/25

Kessel, Christoph

PERIPLO, NCT05925790: Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR Levels

Recruiting

N/A

146

Europe

IL1RA Antibody Assay, suPAR Testing

Pericarditis

07/25

12/25



	Diseases Companies Products Productz Mechanisms of Action Sites